{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-129343","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2022-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.950447+00:00","generated_at":"2026-06-20T23:52:17.321252+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Federal Circuit upholds Collegium's Belbuca patents; blocks Alvogen generic until 2032","bullets":["Alvogen conceded infringement; Federal Circuit ruling bars generic entry until 2032 patent expiry (9,901,539 patent).","Court upheld validity of claims in '866 (2027) and '539 (2032) patents; remanded some claims of '866 and '843 patents (2027) for reconsideration.","Decision reinforces strength of Belbuca patent portfolio, protecting key chronic pain product from generic competition."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-129343","json":"https://secwatch.observer/filing/0001104659-22-129343.json","markdown":"https://secwatch.observer/filing/0001104659-22-129343.md","text":"https://secwatch.observer/filing/0001104659-22-129343.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465922129343/0001104659-22-129343-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465922129343/tm2233280d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:52:17.321252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}